Atlas Trials

Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation

Clinical trial NCT05490082 · UNKNOWN

Trial details

NCT number
NCT05490082
Sponsor
Mansoura University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Voiding Disorders
Start date
2022-03-01
Primary completion
2023-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.